GlaxoSmithKline PLC News Headlines

GSK 
$45.79
*  
0.43
0.95%
Get GSK Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    GSK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
China Biotech Week In Review: Chindex Taken Private By Fosun And TPG
4/27/2014 2:39:00 AM - Seeking Alpha


Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2014 Update
4/25/2014 1:31:00 PM - Seeking Alpha


Novartis Misses on Earnings & Revs in Q1 - Analyst Blog
4/25/2014 12:00:01 PM - Zacks.com


Update on Glaxo/Theravance's COPD Drugs - Analyst Blog
4/24/2014 6:33:01 PM - Zacks.com


Almirall Quietly Building A Better Business
4/24/2014 12:57:00 AM - Seeking Alpha


Epizyme Up on Milestone Payment from Glaxo - Analyst Blog
4/23/2014 7:10:01 PM - Zacks.com


Novartis Signs Deals With GlaxoSmithKline & Eli Lilly - Analyst Blog
4/23/2014 6:40:01 PM - Zacks.com


Novartis Signs Deals with Glaxo, Lilly - Analyst Blog
4/23/2014 4:40:01 PM - Zacks.com


Stock Market News for April 23, 2014 - Market News
4/23/2014 10:06:01 AM - Zacks.com


Closing Update: Strong Earnings, Deal-Making Add Up to Another Winning Day for Stocks
4/22/2014 4:15:27 PM - MT Newswires


Healthcare Stocks Again Rising; Novartis, GSK and Lilly in $28.5 Bln Swap of Operating Units
4/22/2014 1:10:07 PM - MT Newswires


Sector Update: Healthcare
4/22/2014 12:50:08 PM - MT Newswires


Today's Market: Why Today's Deals Will Lead To More
4/22/2014 11:58:00 AM - Seeking Alpha


Why Glaxo bids adieu to cancer drugs
4/22/2014 10:42:00 AM - Seeking Alpha


Futures Reflect Investor Reluctance Despite Upbeat Earnings and Pharma M&A
4/22/2014 9:10:35 AM - MT Newswires


Has Theravance Just Given Away 40% Of Its Value?
4/22/2014 8:43:00 AM - Seeking Alpha


New GlaxoSmithKline Diabetes Drug Needs Innovative Marketing Strategy
4/21/2014 1:44:00 PM - Seeking Alpha


Sector Update: Health Care
4/21/2014 8:22:04 AM - MT Newswires


Sector Update: Health-Care Shares Flat Pre-Market; Sarepta Soars 75% on New Drug Application Plans for Eteplirsen
4/21/2014 8:18:57 AM - MT Newswires


10 Of 17 Top Sin Stocks Stalk 7% To 22% Upsides
4/18/2014 10:38:00 AM - Seeking Alpha


Glaxo Looking into Misconduct Charges - Analyst Blog
4/17/2014 6:35:01 PM - Zacks.com


Pharmaceutical Stocks For Income, Value And Growth Investors
4/17/2014 12:46:16 PM - Benzinga


Glaxo's Tanzeum Approved in the U.S. - Analyst Blog
4/16/2014 6:33:01 PM - Zacks.com


Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog
4/16/2014 4:10:01 PM - Zacks.com


Mylan Inks Two Separate Agreements - Analyst Blog
4/16/2014 11:10:01 AM - Zacks.com